FR2398498A1 - Compositions stabilisees a usage pharmacologique contenant un analogue de la prostaglandine i2 - Google Patents

Compositions stabilisees a usage pharmacologique contenant un analogue de la prostaglandine i2

Info

Publication number
FR2398498A1
FR2398498A1 FR7831038A FR7831038A FR2398498A1 FR 2398498 A1 FR2398498 A1 FR 2398498A1 FR 7831038 A FR7831038 A FR 7831038A FR 7831038 A FR7831038 A FR 7831038A FR 2398498 A1 FR2398498 A1 FR 2398498A1
Authority
FR
France
Prior art keywords
prostaglandin
stabilized compositions
use containing
pharmacological use
containing analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7831038A
Other languages
English (en)
Other versions
FR2398498B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2398498A1 publication Critical patent/FR2398498A1/fr
Application granted granted Critical
Publication of FR2398498B1 publication Critical patent/FR2398498B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des compositions stabilisées contenant un analogue de la protaglandine I2 (PGI2 ). Ces compositions sont caractérisées en ce qu'elles contiennent, ou quelles sont constituées par, un clathrate de cyclodextrine de l'analogue de PGI2 . Applications pharmacologiques, notamment pour le traitement de l'artériosclérose, des défaillances cardiaques et de la thrombose.
FR7831038A 1977-05-06 1978-11-02 Compositions stabilisees a usage pharmacologique contenant un analogue de la prostaglandine i2 Granted FR2398498A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5127877A JPS53136513A (en) 1977-05-06 1977-05-06 Stabilization of prostaglandin-x-related compounds

Publications (2)

Publication Number Publication Date
FR2398498A1 true FR2398498A1 (fr) 1979-02-23
FR2398498B1 FR2398498B1 (fr) 1982-12-17

Family

ID=12882465

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7813047A Expired FR2389375B1 (fr) 1977-05-06 1978-05-03
FR7831038A Granted FR2398498A1 (fr) 1977-05-06 1978-11-02 Compositions stabilisees a usage pharmacologique contenant un analogue de la prostaglandine i2

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7813047A Expired FR2389375B1 (fr) 1977-05-06 1978-05-03

Country Status (5)

Country Link
US (1) US4479944A (fr)
JP (1) JPS53136513A (fr)
DE (1) DE2819447A1 (fr)
FR (2) FR2389375B1 (fr)
GB (2) GB1604162A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179141B (fr) * 1977-09-23 1982-08-28
DE2811950A1 (de) * 1978-03-18 1979-12-13 Hoechst Ag Neue analoga von prostacyclin
US4430340A (en) * 1978-07-17 1984-02-07 The Upjohn Company Stabilization of PGI2 compounds with surfactants
DE2902809A1 (de) 1979-01-25 1980-08-07 Hoechst Ag Neue analoga von prostacyclin
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
US4303671A (en) 1980-07-10 1981-12-01 The Upjohn Company Albumin stabilized prostacyclin
JPS6013779A (ja) * 1983-07-05 1985-01-24 Green Cross Corp:The プロスタグランジンｉ↓２誘導体
KR880012221A (ko) * 1987-04-13 1988-11-26 사노 가즈오 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
US5602112A (en) 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010466A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010486A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070009532A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100745A1 (fr) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co
FR2378777A1 (fr) * 1977-01-31 1978-08-25 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines
FR2381043A1 (fr) * 1977-02-21 1978-09-15 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2404006A1 (fr) * 1977-09-23 1979-04-20 Chinoin Gyogyszer Es Vegyeszet Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3829579A (en) * 1971-11-01 1974-08-13 Upjohn Co Stable solutions of pge-type compounds
DE2357953A1 (de) * 1973-11-21 1975-05-28 Hoechst Ag Neue, natuerlich nicht vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung
US4070537A (en) * 1975-05-30 1978-01-24 Ono Pharmaceutical Company 17-Oxo-17-phenyl-prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
GB1595056A (en) * 1976-10-12 1981-08-05 Wellcome Found Pharmaceutical combination
JPS54115368A (en) * 1978-03-01 1979-09-07 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition containing it as active constituent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100745A1 (fr) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co
FR2378777A1 (fr) * 1977-01-31 1978-08-25 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines
FR2381043A1 (fr) * 1977-02-21 1978-09-15 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2404006A1 (fr) * 1977-09-23 1979-04-20 Chinoin Gyogyszer Es Vegyeszet Complexes d'inclusion de prostacycline et de derives de prostacycline avec des cyclodextrines, leur preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2389375A1 (fr) 1978-12-01
JPS53136513A (en) 1978-11-29
US4479944A (en) 1984-10-30
FR2398498B1 (fr) 1982-12-17
DE2819447A1 (de) 1978-11-09
GB1604162A (en) 1981-12-02
GB1604161A (en) 1981-12-02
FR2389375B1 (fr) 1982-08-06

Similar Documents

Publication Publication Date Title
FR2398498A1 (fr) Compositions stabilisees a usage pharmacologique contenant un analogue de la prostaglandine i2
IT1206341B (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
NO962187D0 (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
GB1534823A (en) Dental chairs or like patient supporting devices
ATE150975T1 (de) Peripheralisierung hämatopoietischer stammzellen
AP9200410A0 (en) Retroviral protease inhibitors.
NZ179503A (en) 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-w-pentanorprostaglandins and pharmaceutical compositions
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
SE9603669D0 (sv) New combination
FR2662354B1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.
DE69033970D1 (de) Huperzin a analoge verbindungen
IT1200657B (it) Benzammidi sostituite farmacologicamente attive utili per il trattamento della emesi da chemioterapia
ATE78031T1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
IT1212141B (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
FR2398067A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
BE876296A (fr) Compositions pharmaceutiques contenant des prostaglandines
FR2361380A1 (fr) Nouveaux analogues de prostaglandines et leur preparation
ES8101538A1 (es) Procedimiento de preparacion de los aaa-trifluoro (aminoa- ril)etanoles o de un acido hetero arilcarboxilico,asi como de sus sales de adicion con un acido mineral u organico
IT1136568B (it) Composizioni per l'idratazione delle sostanze cheratiniche,costutuite da solfossidi di alfa-ammino-acidi
IT1189379B (it) Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico
FR2434623A1 (fr) Composition antibacterienne a la trimethoprime comprenant un sulfonamide et du phenoxyethanol
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
FR2422667A1 (fr) Derives de 7a-methoxycephalosporine, leur procede de preparation et leur application en therapeutique
GT197749830A (es) Procedimiento para preparar cianoguanidinas

Legal Events

Date Code Title Description
ST Notification of lapse